TG Therapeutics, Inc.
US ˙ NasdaqCM ˙ US88322Q1085

SecurityTGTX / TG Therapeutics, Inc.
InstitutionWolverine Trading, Llc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Wolverine Trading, Llc ownership in TGTX / TG Therapeutics, Inc.

On August 18, 2025 - Wolverine Trading, Llc filed a 13F-HR form disclosing ownership of 0 shares of TG Therapeutics, Inc. (US:TGTX) valued at $0 USD as of June 30, 2025. The entity filed a previous 13F-HR on May 15, 2025 disclosing 6,120 shares of TG Therapeutics, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Wolverine Trading, Llc has a history of taking positions in derivatives of the underlying security (TGTX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

TGTX / TG Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-18 2025-06-30 13F TG THERAPEUTICS COM 88322Q108 0 -6,120 -100.00 0 -100.00
2025-05-15 2025-03-31 13F TG THERAPEUTICS COM 88322Q108 6,120 -34,627 -84.98 244 -81.03 0.0003
2025-02-14 2024-12-31 13F TG THERAPEUTICS COM 88322Q108 40,747 28,468 231.84 1,281 338.70 0.0012
2024-11-14 2024-09-30 13F TG THERAPEUTICS COM 88322Q108 12,279 -2,483 -16.82 293 11.45 0.0003
2024-08-14 2024-06-30 13F TG THERAPEUTICS COM 88322Q108 14,762 -29,478 -66.63 263 -61.01 0.0003
2024-05-15 2024-03-31 13F TG THERAPEUTICS COM 88322Q108 44,240 44,240 673 0.0007
2024-02-14 2023-12-31 13F TG THERAPEUTICS COM 88322Q108 0 -24,155 -100.00 0 -100.00
2023-11-15 2023-09-30 13F TG THERAPEUTICS COM 88322Q108 24,155 -3,744 -13.42 202 -70.09 0.0002
2023-08-23 2023-06-30 13F TG THERAPEUTICS COM 88322Q108 27,899 27,899 673 0.0008
2022-08-15 2022-06-30 13F TG THERAPEUTICS COM 88322Q108 0 -13,720 -100.00 0 -100.00
2022-05-16 2022-03-31 13F TG THERAPEUTICS COM 88322Q108 13,720 -10,008 -42.18 135 -70.59 0.0002
2022-02-14 2021-12-31 13F TG THERAPEUTICS COM 88322Q108 23,728 -606 -2.49 459 -43.82 0.0005
2021-11-12 2021-09-30 13F TG THERAPEUTICS COM 88322Q108 24,334 -5,725 -19.05 817 -27.76 0.0009
2021-08-06 2021-06-30 13F TG THERAPEUTICS COM 88322Q108 30,059 760 2.59 1,131 -14.77 0.0018
2021-05-14 2021-03-31 13F TG THERAPEUTICS COM 88322Q108 29,299 -56,930 -66.02 1,327 -70.91 0.0020
2021-02-12 2020-12-31 13F TG THERAPEUTICS COM 88322Q108 86,229 -8,573 -9.04 4,561 83.84 0.0071
2020-11-13 2020-09-30 13F TG THERAPEUTICS COM 88322Q108 94,802 14,387 17.89 2,481 66.06 0.0060
2020-08-13 2020-06-30 13F TG THERAPEUTICS COM 88322Q108 80,415 -23,003 -22.24 1,494 40.02 0.0041
2020-05-11 2020-03-31 13F TG THERAPEUTICS COM 88322Q108 103,418 942 0.92 1,067 -4.05 0.0032
2020-02-12 2019-12-31 13F TG THERAPEUTICS COM 88322Q108 102,476 2,619 2.62 1,112 97.16 0.0027
2019-11-14 2019-09-30 13F TG THERAPEUTICS COM 88322Q108 99,857 19,764 24.68 564 -18.61 0.0016
2019-08-20 2019-06-30 13F TG THERAPEUTICS COM 88322Q108 80,093 -61,208 -43.32 693 -39.00 0.0020
2019-05-15 2019-03-31 13F TG THERAPEUTICS COM 88322Q108 141,301 68,171 93.22 1,136 290.38 0.0033
2019-02-13 2018-12-31 13F TG THERAPEUTICS COM 88322Q108 73,130 25,295 52.88 291 8.58 0.0008
2018-11-14 2018-09-30 13F TG THERAPEUTICS COM 88322Q108 47,835 29,009 154.09 268 0.37 0.0006
2018-08-13 2018-06-30 13F TG THERAPEUTICS COM 88322Q108 18,826 0 0.00 267 0.00 0.0006
2018-05-15 2018-03-31 13F TG THERAPEUTICS COM 88322Q108 18,826 18,826 267 0.0006
2017-11-15 2017-09-30 13F TG THERAPEUTICS COM 88322Q108 0 -45,150 -100.00 0 -100.00
2017-08-14 2017-06-30 13F TG THERAPEUTICS COM 88322Q108 45,150 33,095 274.53 479 565.28 0.0022
2016-08-17 2016-06-30 13F/A-1 TG THERAPEUTICS COM 88322Q108 12,055 12,055 72 0.0004
2016-08-15 2016-06-30 13F TG THERAPEUTICS COM 88322Q108 12,055 11,965 72
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F TG THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-18 2025-06-30 13F TG THERAPEUTICS COM Call 266,200 21.22 9,775 11.66 n/a n/a n/a
2025-05-15 2025-03-31 13F TG THERAPEUTICS COM Call 219,600 -1.21 8,753 25.22 n/a n/a n/a
2025-02-14 2024-12-31 13F TG THERAPEUTICS COM Call 222,300 32.88 6,990 75.36 n/a n/a n/a
2024-11-14 2024-09-30 13F TG THERAPEUTICS COM Call 167,300 34.92 3,987 80.77 n/a n/a n/a
2024-08-14 2024-06-30 13F TG THERAPEUTICS COM Call 124,000 12.42 2,206 31.48 n/a n/a n/a
2024-05-15 2024-03-31 13F TG THERAPEUTICS COM Call 110,300 -41.14 1,678 -47.59 n/a n/a n/a
2024-02-14 2023-12-31 13F TG THERAPEUTICS COM Call 187,400 40.90 3,201 188.03 n/a n/a n/a
2023-11-15 2023-09-30 13F TG THERAPEUTICS COM Call 133,000 -31.93 1,112 -76.42 n/a n/a n/a
2023-08-23 2023-06-30 13F TG THERAPEUTICS COM Call 195,400 127.21 4,711 471,000.00 n/a n/a n/a
2023-05-15 2023-03-31 13F TG THERAPEUTICS COM Call 86,000 1 n/a n/a n/a
2023-02-14 2022-12-31 13F TG THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-14 2022-09-30 13F TG THERAPEUTICS COM Call 44,800 18.21 268 63.41 n/a n/a n/a
2022-08-15 2022-06-30 13F TG THERAPEUTICS COM Call 37,900 -18.49 164 -64.11 n/a n/a n/a
2022-05-16 2022-03-31 13F TG THERAPEUTICS COM Call 46,500 -34.87 457 -66.93 n/a n/a n/a
2022-02-14 2021-12-31 13F TG THERAPEUTICS COM Call 71,400 28.65 1,382 -25.82 n/a n/a n/a
2021-11-12 2021-09-30 13F TG THERAPEUTICS COM Call 55,500 37.04 1,863 22.32 n/a n/a n/a
2021-08-06 2021-06-30 13F TG THERAPEUTICS COM Call 40,500 20.90 1,523 0.40 n/a n/a n/a
2021-05-14 2021-03-31 13F TG THERAPEUTICS COM Call 33,500 -62.65 1,517 -68.02 n/a n/a n/a
2021-02-12 2020-12-31 13F TG THERAPEUTICS COM Call 89,700 16.34 4,744 135.08 n/a n/a n/a
2020-11-13 2020-09-30 13F TG THERAPEUTICS COM Call 77,100 -23.21 2,018 8.20 n/a n/a n/a
2020-08-13 2020-06-30 13F TG THERAPEUTICS COM Call 100,400 -48.06 1,865 -6.52 n/a n/a n/a
2020-05-11 2020-03-31 13F TG THERAPEUTICS COM Call 193,300 -0.92 1,995 -5.76 n/a n/a n/a
2020-02-12 2019-12-31 13F TG THERAPEUTICS COM Call 195,100 64.92 2,117 216.92 n/a n/a n/a
2019-11-14 2019-09-30 13F TG THERAPEUTICS COM Call 118,300 48.25 668 -3.19 n/a n/a n/a
2019-08-20 2019-06-30 13F TG THERAPEUTICS COM Call 79,800 4.31 690 12.20 n/a n/a n/a
2019-05-15 2019-03-31 13F TG THERAPEUTICS COM Call 76,500 -58.92 615 -17.00 n/a n/a n/a
2019-02-13 2018-12-31 13F TG THERAPEUTICS COM Call 186,200 -13.44 741 -38.51 n/a n/a n/a
2018-11-14 2018-09-30 13F TG THERAPEUTICS COM Call 215,100 1.89 1,205 -59.81 n/a n/a n/a
2018-08-13 2018-06-30 13F TG THERAPEUTICS COM Call 211,100 0.00 2,998 0.00 n/a n/a n/a
2018-05-15 2018-03-31 13F TG THERAPEUTICS COM Call 211,100 2,998 n/a n/a n/a
2018-02-14 2017-12-31 13F TG THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-15 2017-09-30 13F TG THERAPEUTICS COM Call 118,000 76.38 1,398 97.18 n/a n/a n/a
2017-08-14 2017-06-30 13F TG THERAPEUTICS COM Call 66,900 -21.48 709 -27.36 n/a n/a n/a
2017-05-15 2017-03-31 13F TG THERAPEUTICS COM Call 85,200 976 n/a n/a n/a
2016-11-14 2016-09-30 13F TG THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-08-15 2016-06-30 13F TG THERAPEUTICS COM Call 67 40 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F TG THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-18 2025-06-30 13F TG THERAPEUTICS COM Put 100,200 1.31 3,679 -6.67 n/a n/a n/a
2025-05-15 2025-03-31 13F TG THERAPEUTICS COM Put 98,900 -0.90 3,942 25.62 n/a n/a n/a
2025-02-14 2024-12-31 13F TG THERAPEUTICS COM Put 99,800 82.78 3,138 141.20 n/a n/a n/a
2024-11-14 2024-09-30 13F TG THERAPEUTICS COM Put 54,600 -27.97 1,301 -3.49 n/a n/a n/a
2024-08-14 2024-06-30 13F TG THERAPEUTICS COM Put 75,800 -3.93 1,348 12.33 n/a n/a n/a
2024-05-15 2024-03-31 13F TG THERAPEUTICS COM Put 78,900 21.57 1,200 8.30 n/a n/a n/a
2024-02-14 2023-12-31 13F TG THERAPEUTICS COM Put 64,900 16.10 1,108 137.26 n/a n/a n/a
2023-11-15 2023-09-30 13F TG THERAPEUTICS COM Put 55,900 -24.36 467 -73.78 n/a n/a n/a
2023-08-23 2023-06-30 13F TG THERAPEUTICS COM Put 73,900 134.60 1,782 n/a n/a n/a
2023-05-15 2023-03-31 13F TG THERAPEUTICS COM Put 31,500 0 n/a n/a n/a
2023-02-14 2022-12-31 13F TG THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-14 2022-09-30 13F TG THERAPEUTICS COM Put 21,400 -31.63 128 -5.19 n/a n/a n/a
2022-08-15 2022-06-30 13F TG THERAPEUTICS COM Put 31,300 -9.01 135 -60.06 n/a n/a n/a
2022-05-16 2022-03-31 13F TG THERAPEUTICS COM Put 34,400 -34.23 338 -66.60 n/a n/a n/a
2022-02-14 2021-12-31 13F TG THERAPEUTICS COM Put 52,300 -1.69 1,012 -43.34 n/a n/a n/a
2021-11-12 2021-09-30 13F TG THERAPEUTICS COM Put 53,200 -0.19 1,786 -10.92 n/a n/a n/a
2021-08-06 2021-06-30 13F TG THERAPEUTICS COM Put 53,300 8.33 2,005 -10.01 n/a n/a n/a
2021-05-14 2021-03-31 13F TG THERAPEUTICS COM Put 49,200 -47.66 2,228 -55.19 n/a n/a n/a
2021-02-12 2020-12-31 13F TG THERAPEUTICS COM Put 94,000 48.73 4,972 200.60 n/a n/a n/a
2020-11-13 2020-09-30 13F TG THERAPEUTICS COM Put 63,200 -8.93 1,654 28.32 n/a n/a n/a
2020-08-13 2020-06-30 13F TG THERAPEUTICS COM Put 69,400 -23.31 1,289 38.01 n/a n/a n/a
2020-05-11 2020-03-31 13F TG THERAPEUTICS COM Put 90,500 -5.73 934 -10.36 n/a n/a n/a
2020-02-12 2019-12-31 13F TG THERAPEUTICS COM Put 96,000 4.80 1,042 101.16 n/a n/a n/a
2019-11-14 2019-09-30 13F TG THERAPEUTICS COM Put 91,600 43.80 518 -5.99 n/a n/a n/a
2019-08-20 2019-06-30 13F TG THERAPEUTICS COM Put 63,700 -9.52 551 -2.65 n/a n/a n/a
2019-05-15 2019-03-31 13F TG THERAPEUTICS COM Put 70,400 -12.11 566 77.43 n/a n/a n/a
2019-02-13 2018-12-31 13F TG THERAPEUTICS COM Put 80,100 -41.79 319 -58.63 n/a n/a n/a
2018-11-14 2018-09-30 13F TG THERAPEUTICS COM Put 137,600 28.36 771 -49.34 n/a n/a n/a
2018-08-13 2018-06-30 13F TG THERAPEUTICS COM Put 107,200 0.00 1,522 0.00 n/a n/a n/a
2018-05-15 2018-03-31 13F TG THERAPEUTICS COM Put 107,200 1,522 n/a n/a n/a
2018-02-14 2017-12-31 13F TG THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-15 2017-09-30 13F TG THERAPEUTICS COM Put 69,900 20.73 828 34.85 n/a n/a n/a
2017-08-14 2017-06-30 13F TG THERAPEUTICS COM Put 57,900 -3.34 614 -10.50 n/a n/a n/a
2017-05-15 2017-03-31 13F TG THERAPEUTICS COM Put 59,900 686 n/a n/a n/a
2016-11-14 2016-09-30 13F TG THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-08-15 2016-06-30 13F TG THERAPEUTICS COM Put 90 54 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.